

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.04786100 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.04786100 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.64605391 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64605391 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.92320960 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68990486 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.30296043 |
| 8 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00860613 |
| 9 | bile acid biosynthetic process (GO:0006699) | 4.98703040 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.92883980 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.92883980 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.92883980 |
| 13 | urea cycle (GO:0000050) | 4.89515269 |
| 14 | urea metabolic process (GO:0019627) | 4.89515269 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.84180118 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.79487028 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.73618042 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.72996711 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.72758908 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.72758908 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.69247297 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.58221707 |
| 23 | protein carboxylation (GO:0018214) | 4.58221707 |
| 24 | acylglycerol homeostasis (GO:0055090) | 4.53546633 |
| 25 | triglyceride homeostasis (GO:0070328) | 4.53546633 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.52861029 |
| 27 | bile acid metabolic process (GO:0008206) | 4.48201834 |
| 28 | tyrosine metabolic process (GO:0006570) | 4.42529088 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.38742781 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37730321 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.32886374 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.28732430 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.28466230 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 4.27954571 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.26619043 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25967940 |
| 37 | cysteine metabolic process (GO:0006534) | 4.25528850 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19730569 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10458733 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.07090388 |
| 41 | regulation of complement activation (GO:0030449) | 4.01311935 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 3.97917316 |
| 43 | valine metabolic process (GO:0006573) | 3.93257661 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 3.91967285 |
| 45 | bile acid and bile salt transport (GO:0015721) | 3.91939928 |
| 46 | lysine metabolic process (GO:0006553) | 3.91625424 |
| 47 | lysine catabolic process (GO:0006554) | 3.91625424 |
| 48 | phospholipid efflux (GO:0033700) | 3.90937205 |
| 49 | reverse cholesterol transport (GO:0043691) | 3.90644933 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 3.88772492 |
| 51 | coenzyme catabolic process (GO:0009109) | 3.88653282 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 3.85291209 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 3.85291209 |
| 54 | macromolecular complex remodeling (GO:0034367) | 3.85291209 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 3.85174849 |
| 56 | fatty acid beta-oxidation (GO:0006635) | 3.84599378 |
| 57 | fatty acid oxidation (GO:0019395) | 3.80972756 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.80347015 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.80347015 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.79414273 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.72844595 |
| 62 | response to interleukin-15 (GO:0070672) | 3.72811445 |
| 63 | lipid oxidation (GO:0034440) | 3.72146785 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 3.66549940 |
| 65 | fatty acid catabolic process (GO:0009062) | 3.66541358 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.62222125 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.60439872 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.55019471 |
| 69 | monocarboxylic acid catabolic process (GO:0072329) | 3.54806577 |
| 70 | fatty acid homeostasis (GO:0055089) | 3.49883341 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.46255027 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46201303 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.45007662 |
| 74 | cholesterol efflux (GO:0033344) | 3.44170293 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.44134991 |
| 76 | organic acid catabolic process (GO:0016054) | 3.44134991 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 3.43780115 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.42218781 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.41543754 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.35982540 |
| 81 | phospholipid homeostasis (GO:0055091) | 3.35199642 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 3.31604574 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.30064033 |
| 84 | amine catabolic process (GO:0009310) | 3.30064033 |
| 85 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.29834470 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.28779480 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.28779480 |
| 88 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.27413092 |
| 89 | regulation of cholesterol metabolic process (GO:0090181) | 3.26762266 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 3.26054844 |
| 91 | cholesterol homeostasis (GO:0042632) | 3.25141717 |
| 92 | glycine metabolic process (GO:0006544) | 3.23837804 |
| 93 | positive regulation of glycolytic process (GO:0045821) | 3.23325263 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.23064126 |
| 95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.23050603 |
| 96 | cytolysis (GO:0019835) | 3.22861525 |
| 97 | ethanol oxidation (GO:0006069) | 3.22048976 |
| 98 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.20994851 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 3.20259591 |
| 100 | Golgi transport vesicle coating (GO:0048200) | 3.20259591 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20259435 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 3.19268995 |
| 103 | carnitine metabolic process (GO:0009437) | 3.19238628 |
| 104 | lipoprotein metabolic process (GO:0042157) | 3.19089718 |
| 105 | glutamate metabolic process (GO:0006536) | 3.18517269 |
| 106 | tricarboxylic acid metabolic process (GO:0072350) | 3.18491026 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.18445079 |
| 108 | sterol homeostasis (GO:0055092) | 3.18373635 |
| 109 | complement activation (GO:0006956) | 3.18006204 |
| 110 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.17857426 |
| 111 | low-density lipoprotein particle remodeling (GO:0034374) | 3.17471900 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16867882 |
| 113 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16624101 |
| 114 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.15865053 |
| 115 | cofactor catabolic process (GO:0051187) | 3.14733581 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.14165114 |
| 117 | drug catabolic process (GO:0042737) | 3.01387194 |
| 118 | positive regulation of sterol transport (GO:0032373) | 2.98258347 |
| 119 | positive regulation of cholesterol transport (GO:0032376) | 2.98258347 |
| 120 | epoxygenase P450 pathway (GO:0019373) | 2.97299604 |
| 121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96382619 |
| 122 | positive thymic T cell selection (GO:0045059) | 2.83306964 |
| 123 | lymph node development (GO:0048535) | 2.82477015 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.81872565 |
| 125 | macroautophagy (GO:0016236) | 2.78377872 |
| 126 | regulation of memory T cell differentiation (GO:0043380) | 2.76427043 |
| 127 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75173391 |
| 128 | neutrophil activation (GO:0042119) | 2.73663103 |
| 129 | regulation of extracellular matrix disassembly (GO:0010715) | 2.72283075 |
| 130 | negative T cell selection (GO:0043383) | 2.71697881 |
| 131 | regulation of lipoprotein particle clearance (GO:0010984) | 2.68385183 |
| 132 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.67859020 |
| 133 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66630973 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.65226540 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61952445 |
| 136 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61866428 |
| 137 | negative regulation of phagocytosis (GO:0050765) | 2.61800952 |
| 138 | negative thymic T cell selection (GO:0045060) | 2.59391266 |
| 139 | negative regulation of granulocyte differentiation (GO:0030853) | 2.56757420 |
| 140 | ketone body metabolic process (GO:1902224) | 2.55502122 |
| 141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.52548500 |
| 142 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52181803 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.49888655 |
| 144 | positive regulation of cholesterol efflux (GO:0010875) | 2.49595277 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.47534003 |
| 146 | peptide hormone processing (GO:0016486) | 2.46712070 |
| 147 | interferon-gamma production (GO:0032609) | 2.44545196 |
| 148 | retinol metabolic process (GO:0042572) | 2.43902928 |
| 149 | ethanol metabolic process (GO:0006067) | 2.41722877 |
| 150 | regulation of granulocyte differentiation (GO:0030852) | 2.41220534 |
| 151 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.40033576 |
| 152 | zinc ion homeostasis (GO:0055069) | 2.37460973 |
| 153 | negative regulation of protein autophosphorylation (GO:0031953) | 2.36149640 |
| 154 | granulocyte activation (GO:0036230) | 2.35316321 |
| 155 | oligosaccharide catabolic process (GO:0009313) | 2.35179255 |
| 156 | positive regulation of granulocyte differentiation (GO:0030854) | 2.34040406 |
| 157 | regulation of triglyceride metabolic process (GO:0090207) | 2.33790829 |
| 158 | drug metabolic process (GO:0017144) | 2.32356188 |
| 159 | tolerance induction (GO:0002507) | 2.31578492 |
| 160 | thymic T cell selection (GO:0045061) | 2.31444537 |
| 161 | primary alcohol metabolic process (GO:0034308) | 2.30357651 |
| 162 | diacylglycerol metabolic process (GO:0046339) | 2.29417586 |
| 163 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29195155 |
| 164 | regulation of cell killing (GO:0031341) | 2.29044423 |
| 165 | triglyceride catabolic process (GO:0019433) | 2.26467733 |
| 166 | lipid storage (GO:0019915) | 2.26334935 |
| 167 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.26334180 |
| 168 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.26334180 |
| 169 | omega-hydroxylase P450 pathway (GO:0097267) | 2.23683951 |
| 170 | positive T cell selection (GO:0043368) | 2.23254552 |
| 171 | regulation of cellular extravasation (GO:0002691) | 2.22998257 |
| 172 | cellular glucuronidation (GO:0052695) | 2.22643274 |
| 173 | detection of bacterium (GO:0016045) | 2.22313707 |
| 174 | T cell selection (GO:0045058) | 2.21455414 |
| 175 | S-adenosylmethionine metabolic process (GO:0046500) | 2.21409182 |
| 176 | negative regulation of interleukin-6 production (GO:0032715) | 2.20817632 |
| 177 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.20775580 |
| 178 | phenylpropanoid metabolic process (GO:0009698) | 2.20336965 |
| 179 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.19997773 |
| 180 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.19379699 |
| 181 | regulation of sterol transport (GO:0032371) | 2.17994867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.92390414 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31476343 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.28614540 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.69500295 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67843175 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.56609900 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81287866 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.71611769 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81728945 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.28562801 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75582030 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.65895704 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.60038231 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.56657366 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37799204 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.31947886 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28856755 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96458220 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86991977 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83633584 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76745307 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66963661 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64330155 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60159788 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.58417537 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55774939 |
| 27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45561847 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45391939 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44965226 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42904172 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39340188 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38965440 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38887623 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.38880123 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37143994 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36933647 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35888263 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35802062 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33803401 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.24696896 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24116933 |
| 42 | P300_27268052_Chip-Seq_Bcells_Human | 1.21246989 |
| 43 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17557402 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16311145 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15642963 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12334232 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.11051396 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10491958 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08848371 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06899772 |
| 51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06368926 |
| 52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05802084 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05012440 |
| 54 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03753480 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03443197 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03301083 |
| 57 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02039762 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01332777 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01244517 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00872090 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00751385 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00172254 |
| 63 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99645373 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99246526 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98871216 |
| 66 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98744396 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98108558 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97899290 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97706885 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96531365 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.96180638 |
| 72 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95869195 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95462922 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95204949 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94704939 |
| 76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94096803 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92864168 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92199646 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91572699 |
| 80 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91385396 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91140662 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90603604 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90539633 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89928053 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86674682 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86438977 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86137153 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86067808 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85903272 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.85014745 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.85007621 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82797119 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80890216 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79478069 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79169350 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79113185 |
| 97 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78479608 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77567866 |
| 99 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77520032 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77122687 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76036403 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75572643 |
| 103 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74925258 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74493449 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.73823005 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.73491516 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.71885778 |
| 108 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71494958 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70642536 |
| 110 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70520350 |
| 111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69952200 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69778767 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69346818 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69002219 |
| 115 | MYC_22102868_ChIP-Seq_BL_Human | 0.68509777 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64815724 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64717090 |
| 118 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64642076 |
| 119 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64557206 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.63767742 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62612582 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61946128 |
| 123 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61886632 |
| 124 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.61359385 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61262129 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61096752 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.60561695 |
| 128 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.58646093 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.58279006 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.57820829 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56174817 |
| 132 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.55871072 |
| 133 | MYB_26560356_Chip-Seq_TH1_Human | 0.55458585 |
| 134 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.55325805 |
| 135 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55218937 |
| 136 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.54709447 |
| 137 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54292983 |
| 138 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.53829708 |
| 139 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.53764505 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53718393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.10919958 |
| 2 | MP0005365_abnormal_bile_salt | 5.86366357 |
| 3 | MP0005360_urolithiasis | 5.84008552 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.19338530 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.19303428 |
| 6 | MP0003252_abnormal_bile_duct | 3.65555082 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.49995229 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.03297515 |
| 9 | MP0003195_calcinosis | 2.95227047 |
| 10 | MP0009840_abnormal_foam_cell | 2.88313108 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.65840772 |
| 12 | MP0005083_abnormal_biliary_tract | 2.42555748 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.33031931 |
| 14 | MP0000609_abnormal_liver_physiology | 2.27940324 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.27384543 |
| 16 | MP0005332_abnormal_amino_acid | 2.26501280 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.21869277 |
| 18 | MP0005670_abnormal_white_adipose | 2.09448604 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.93493499 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 1.84648239 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.84501252 |
| 22 | MP0003868_abnormal_feces_composition | 1.84225058 |
| 23 | MP0005387_immune_system_phenotype | 1.80919675 |
| 24 | MP0001790_abnormal_immune_system | 1.80919675 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.79020152 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.73729348 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.73540281 |
| 28 | MP0001800_abnormal_humoral_immune | 1.73246408 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.64715304 |
| 30 | MP0001764_abnormal_homeostasis | 1.59766420 |
| 31 | MP0002723_abnormal_immune_serum | 1.56747688 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.56481798 |
| 33 | MP0002078_abnormal_glucose_homeostasis | 1.56385947 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.56142728 |
| 35 | MP0003724_increased_susceptibility_to | 1.54474440 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.52812890 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.52368933 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.51915886 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.50590941 |
| 40 | MP0001819_abnormal_immune_cell | 1.50457323 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49012084 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.48242190 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.47639921 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.45723176 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.44579706 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.44414457 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.41954803 |
| 48 | MP0001873_stomach_inflammation | 1.40908449 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.38816835 |
| 50 | MP0004130_abnormal_muscle_cell | 1.35441507 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.28106653 |
| 52 | MP0002971_abnormal_brown_adipose | 1.28081887 |
| 53 | MP0002405_respiratory_system_inflammati | 1.26248433 |
| 54 | MP0003186_abnormal_redox_activity | 1.26026564 |
| 55 | MP0000598_abnormal_liver_morphology | 1.22871376 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.22241667 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.20753984 |
| 58 | MP0005334_abnormal_fat_pad | 1.19903294 |
| 59 | MP0008469_abnormal_protein_level | 1.17052269 |
| 60 | MP0004947_skin_inflammation | 1.15836256 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.13005940 |
| 62 | MP0009763_increased_sensitivity_to | 1.11954383 |
| 63 | MP0002928_abnormal_bile_duct | 1.11455829 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.11344484 |
| 65 | MP0009697_abnormal_copulation | 1.11302177 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.10218543 |
| 67 | MP0000716_abnormal_immune_system | 1.09781447 |
| 68 | MP0005535_abnormal_body_temperature | 1.08774844 |
| 69 | MP0009642_abnormal_blood_homeostasis | 1.07787629 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.07300774 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.05964801 |
| 72 | MP0001851_eye_inflammation | 1.05027546 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.04552835 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.04132846 |
| 75 | MP0002006_tumorigenesis | 1.03949998 |
| 76 | MP0003300_gastrointestinal_ulcer | 1.02686149 |
| 77 | MP0003436_decreased_susceptibility_to | 1.02240475 |
| 78 | MP0003283_abnormal_digestive_organ | 1.02180690 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 1.00597880 |
| 80 | MP0005448_abnormal_energy_balance | 1.00186907 |
| 81 | MP0003878_abnormal_ear_physiology | 0.99990018 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.99990018 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.99779787 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.98558667 |
| 85 | MP0002398_abnormal_bone_marrow | 0.98169826 |
| 86 | MP0002009_preneoplasia | 0.95850590 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.95632549 |
| 88 | MP0004043_abnormal_pH_regulation | 0.93869592 |
| 89 | MP0002722_abnormal_immune_system | 0.92034747 |
| 90 | MP0002933_joint_inflammation | 0.91829389 |
| 91 | MP0003879_abnormal_hair_cell | 0.91665334 |
| 92 | MP0001661_extended_life_span | 0.90960284 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.90456446 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.89761547 |
| 95 | MP0002970_abnormal_white_adipose | 0.89242242 |
| 96 | MP0003953_abnormal_hormone_level | 0.87795189 |
| 97 | MP0001756_abnormal_urination | 0.87615787 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.86835520 |
| 99 | MP0002429_abnormal_blood_cell | 0.85581657 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.84471889 |
| 101 | MP0002132_abnormal_respiratory_system | 0.83196558 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.80803524 |
| 103 | MP0009764_decreased_sensitivity_to | 0.78847073 |
| 104 | MP0000604_amyloidosis | 0.78255026 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.78020752 |
| 106 | MP0000685_abnormal_immune_system | 0.76283750 |
| 107 | MP0003011_delayed_dark_adaptation | 0.73482205 |
| 108 | MP0005647_abnormal_sex_gland | 0.73209755 |
| 109 | MP0003959_abnormal_lean_body | 0.72721598 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.72651370 |
| 111 | MP0005451_abnormal_body_composition | 0.72111646 |
| 112 | MP0002254_reproductive_system_inflammat | 0.70183225 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.70156423 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.70070939 |
| 115 | MP0005671_abnormal_response_to | 0.65760834 |
| 116 | MP0005408_hypopigmentation | 0.64203355 |
| 117 | MP0006082_CNS_inflammation | 0.61419451 |
| 118 | MP0009115_abnormal_fat_cell | 0.59977235 |
| 119 | MP0009785_altered_susceptibility_to | 0.59723027 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.59469434 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.59134789 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.58420444 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.57709914 |
| 124 | MP0005025_abnormal_response_to | 0.57286429 |
| 125 | MP0000371_diluted_coat_color | 0.57229536 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.56664757 |
| 127 | MP0002419_abnormal_innate_immunity | 0.55856497 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.52261965 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.50774874 |
| 130 | MP0003866_abnormal_defecation | 0.50577818 |
| 131 | MP0008873_increased_physiological_sensi | 0.50573986 |
| 132 | MP0001835_abnormal_antigen_presentation | 0.50511918 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.48522013 |
| 134 | MP0005266_abnormal_metabolism | 0.47769201 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.46488450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.94786480 |
| 2 | Hypoglycemic coma (HP:0001325) | 5.94905988 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.72814208 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.44358262 |
| 5 | Xanthomatosis (HP:0000991) | 5.30914513 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.26539260 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.11978834 |
| 8 | Hypoglycemic seizures (HP:0002173) | 4.96526384 |
| 9 | Complement deficiency (HP:0004431) | 4.86047609 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.78379076 |
| 11 | Ketosis (HP:0001946) | 4.74767400 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.59297057 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.43764995 |
| 14 | Ketoacidosis (HP:0001993) | 4.19783741 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09524970 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.90249778 |
| 17 | Symptomatic seizures (HP:0011145) | 3.86367139 |
| 18 | Hyperammonemia (HP:0001987) | 3.86183036 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85417700 |
| 20 | Joint hemorrhage (HP:0005261) | 3.82270553 |
| 21 | Epidermoid cyst (HP:0200040) | 3.80594380 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.67938314 |
| 23 | Orchitis (HP:0100796) | 3.61793675 |
| 24 | Abnormality of complement system (HP:0005339) | 3.60576019 |
| 25 | Myositis (HP:0100614) | 3.60386436 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57986555 |
| 27 | Hyperglycinemia (HP:0002154) | 3.54776113 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.48988214 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45139001 |
| 30 | Hyperglycinuria (HP:0003108) | 3.39861263 |
| 31 | Optic neuritis (HP:0100653) | 3.39595075 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.39595075 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.34714341 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.34714341 |
| 35 | Late onset (HP:0003584) | 3.32408928 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.31032271 |
| 37 | Generalized aminoaciduria (HP:0002909) | 3.29723877 |
| 38 | Stomatitis (HP:0010280) | 3.28311210 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.27878857 |
| 40 | Fat malabsorption (HP:0002630) | 3.24945148 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.20114258 |
| 42 | Hyperglycemia (HP:0003074) | 3.19338211 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.00788338 |
| 44 | Hyperbilirubinemia (HP:0002904) | 2.96693666 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.96088208 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.91510329 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.91510329 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.91238821 |
| 49 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.87602641 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.84760450 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.84760450 |
| 52 | Skin nodule (HP:0200036) | 2.78596227 |
| 53 | Increased CSF protein (HP:0002922) | 2.76147233 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74165042 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.71914168 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.69684980 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68040620 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.64401625 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64377746 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.64329988 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.59409261 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.55914086 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53581799 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53581799 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53581799 |
| 66 | Metabolic acidosis (HP:0001942) | 2.52815042 |
| 67 | Glomerulonephritis (HP:0000099) | 2.52413235 |
| 68 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.52352184 |
| 69 | Insulin resistance (HP:0000855) | 2.51594368 |
| 70 | Retinal atrophy (HP:0001105) | 2.50368329 |
| 71 | Brushfield spots (HP:0001088) | 2.48707864 |
| 72 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.46319622 |
| 73 | Albinism (HP:0001022) | 2.45979746 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.45742681 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45342241 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45342241 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.44554292 |
| 78 | Irritability (HP:0000737) | 2.43087753 |
| 79 | Myocardial infarction (HP:0001658) | 2.42019721 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.40744849 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 2.39479515 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.37919169 |
| 83 | Gout (HP:0001997) | 2.37832248 |
| 84 | Thyroiditis (HP:0100646) | 2.36425068 |
| 85 | Vascular calcification (HP:0004934) | 2.35850371 |
| 86 | Pancreatitis (HP:0001733) | 2.34509474 |
| 87 | Abnormality of serum amino acid levels (HP:0003112) | 2.32912797 |
| 88 | Vasculitis (HP:0002633) | 2.32002215 |
| 89 | Meningitis (HP:0001287) | 2.31474929 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.30393868 |
| 91 | Recurrent bacterial skin infections (HP:0005406) | 2.29022023 |
| 92 | Polygenic inheritance (HP:0010982) | 2.27801253 |
| 93 | Severe combined immunodeficiency (HP:0004430) | 2.27074999 |
| 94 | Chronic diarrhea (HP:0002028) | 2.26724771 |
| 95 | Episodic fever (HP:0001954) | 2.26411704 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.26410731 |
| 97 | Hemoptysis (HP:0002105) | 2.25967906 |
| 98 | Growth hormone excess (HP:0000845) | 2.21222689 |
| 99 | Steatorrhea (HP:0002570) | 2.20714967 |
| 100 | Joint swelling (HP:0001386) | 2.19228595 |
| 101 | Lethargy (HP:0001254) | 2.19054471 |
| 102 | Pulmonary embolism (HP:0002204) | 2.17750026 |
| 103 | Cheilitis (HP:0100825) | 2.17449201 |
| 104 | Mitral stenosis (HP:0001718) | 2.14217422 |
| 105 | Recurrent skin infections (HP:0001581) | 2.13365764 |
| 106 | Hemorrhage of the eye (HP:0011885) | 2.13299396 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.12393899 |
| 108 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12087849 |
| 109 | Cardiovascular calcification (HP:0011915) | 2.10410030 |
| 110 | Menorrhagia (HP:0000132) | 2.08119575 |
| 111 | Inflammation of the large intestine (HP:0002037) | 2.07919231 |
| 112 | Large for gestational age (HP:0001520) | 2.07548627 |
| 113 | Abnormality of vitamin B metabolism (HP:0004340) | 2.07504722 |
| 114 | Keratoconjunctivitis (HP:0001096) | 2.07446106 |
| 115 | Gastrointestinal inflammation (HP:0004386) | 2.07285445 |
| 116 | Mucopolysacchariduria (HP:0008155) | 2.06911363 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06911363 |
| 118 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06751158 |
| 119 | Limb hypertonia (HP:0002509) | 2.05574889 |
| 120 | Stridor (HP:0010307) | 2.05419954 |
| 121 | Abnormality of vitamin metabolism (HP:0100508) | 2.05208135 |
| 122 | Hematochezia (HP:0002573) | 2.04949054 |
| 123 | Gingival bleeding (HP:0000225) | 2.04565103 |
| 124 | Spontaneous abortion (HP:0005268) | 2.03753895 |
| 125 | Pustule (HP:0200039) | 2.03600953 |
| 126 | Enlarged kidneys (HP:0000105) | 2.03267740 |
| 127 | Acanthocytosis (HP:0001927) | 2.01353175 |
| 128 | Dysostosis multiplex (HP:0000943) | 2.01112689 |
| 129 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00885484 |
| 130 | Renal cortical cysts (HP:0000803) | 1.97459179 |
| 131 | Hypophosphatemia (HP:0002148) | 1.96402266 |
| 132 | Bone cyst (HP:0012062) | 1.95909349 |
| 133 | Acute hepatic failure (HP:0006554) | 1.95893990 |
| 134 | Encephalitis (HP:0002383) | 1.95183904 |
| 135 | Tetany (HP:0001281) | 1.94294328 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94223884 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94223884 |
| 138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94223884 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 1.93707988 |
| 140 | Abnormal gallbladder morphology (HP:0012437) | 1.93169972 |
| 141 | Malnutrition (HP:0004395) | 1.92916736 |
| 142 | Tongue fasciculations (HP:0001308) | 1.92540851 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 1.92285509 |
| 144 | Cerebral edema (HP:0002181) | 1.90289008 |
| 145 | Hypertriglyceridemia (HP:0002155) | 1.90206464 |
| 146 | Acne (HP:0001061) | 1.89289115 |
| 147 | Epiphyseal stippling (HP:0010655) | 1.87660428 |
| 148 | J-shaped sella turcica (HP:0002680) | 1.87612382 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87239205 |
| 150 | Obstructive lung disease (HP:0006536) | 1.87239205 |
| 151 | Elevated hepatic transaminases (HP:0002910) | 1.87127125 |
| 152 | Petechiae (HP:0000967) | 1.86498381 |
| 153 | Oligomenorrhea (HP:0000876) | 1.86476002 |
| 154 | Arterial thrombosis (HP:0004420) | 1.86359274 |
| 155 | Vomiting (HP:0002013) | 1.84581647 |
| 156 | Neonatal onset (HP:0003623) | 1.84285174 |
| 157 | Abnormality of T cells (HP:0002843) | 1.83345474 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.82960229 |
| 159 | Glycosuria (HP:0003076) | 1.82960229 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.81843785 |
| 161 | Amyloidosis (HP:0011034) | 1.81353147 |
| 162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80447899 |
| 163 | Facial shape deformation (HP:0011334) | 1.79407835 |
| 164 | Potter facies (HP:0002009) | 1.79407835 |
| 165 | Hepatic necrosis (HP:0002605) | 1.79200874 |
| 166 | Myoglobinuria (HP:0002913) | 1.78636058 |
| 167 | Death in childhood (HP:0003819) | 1.78544321 |
| 168 | Esophageal varix (HP:0002040) | 1.77898056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.62382219 |
| 2 | BCKDK | 4.86817481 |
| 3 | ERN1 | 4.52061913 |
| 4 | FLT3 | 3.61811036 |
| 5 | MAPK15 | 3.57560827 |
| 6 | SIK1 | 3.30151670 |
| 7 | TAOK3 | 2.78037108 |
| 8 | PASK | 2.62648068 |
| 9 | TNK2 | 2.60406404 |
| 10 | FGFR4 | 2.59976785 |
| 11 | TRIB3 | 2.17618729 |
| 12 | CAMK1D | 1.86722606 |
| 13 | FES | 1.81430430 |
| 14 | ZAP70 | 1.78866764 |
| 15 | RIPK4 | 1.70823329 |
| 16 | MAP2K3 | 1.66429546 |
| 17 | ACVR1B | 1.63478918 |
| 18 | TLK1 | 1.59435872 |
| 19 | TGFBR2 | 1.57497015 |
| 20 | ITK | 1.55932778 |
| 21 | PIK3CG | 1.54566212 |
| 22 | FRK | 1.52215333 |
| 23 | MST4 | 1.51973667 |
| 24 | PKN2 | 1.49299426 |
| 25 | TYK2 | 1.48931206 |
| 26 | HIPK2 | 1.43741941 |
| 27 | MAP4K1 | 1.42161281 |
| 28 | MAPK11 | 1.33561212 |
| 29 | IRAK3 | 1.31876141 |
| 30 | TBK1 | 1.31604091 |
| 31 | BTK | 1.29499630 |
| 32 | TRPM7 | 1.25069397 |
| 33 | JAK3 | 1.20511010 |
| 34 | DAPK2 | 1.20398925 |
| 35 | FGFR3 | 1.19735569 |
| 36 | PTK6 | 1.18512150 |
| 37 | GRK1 | 1.17143177 |
| 38 | EEF2K | 1.16612149 |
| 39 | BLK | 1.16277706 |
| 40 | PDPK1 | 1.14666284 |
| 41 | PRKD2 | 1.11833381 |
| 42 | JAK1 | 1.11807795 |
| 43 | CAMKK2 | 1.11426729 |
| 44 | TEC | 1.10787812 |
| 45 | CAMK1G | 1.10149222 |
| 46 | DYRK1B | 1.07371146 |
| 47 | KIT | 1.07010005 |
| 48 | JAK2 | 1.06052130 |
| 49 | PDK1 | 1.05527993 |
| 50 | CSK | 1.03627153 |
| 51 | MAPKAPK3 | 1.03243282 |
| 52 | EPHB1 | 1.01988533 |
| 53 | MAP3K13 | 1.01012463 |
| 54 | BMPR2 | 1.00099252 |
| 55 | CSF1R | 0.98013611 |
| 56 | PRKCQ | 0.95616958 |
| 57 | MAP2K6 | 0.94344228 |
| 58 | NLK | 0.92793048 |
| 59 | MAP2K4 | 0.92120269 |
| 60 | FGFR2 | 0.91937572 |
| 61 | MAP3K6 | 0.91823644 |
| 62 | HCK | 0.89035876 |
| 63 | PRKAA2 | 0.86762983 |
| 64 | STK10 | 0.83865811 |
| 65 | IRAK1 | 0.81513926 |
| 66 | WNK3 | 0.80907789 |
| 67 | KDR | 0.80760012 |
| 68 | CDK4 | 0.80569154 |
| 69 | PTK2 | 0.79457881 |
| 70 | IGF1R | 0.79057084 |
| 71 | MAP3K3 | 0.77314342 |
| 72 | EPHA3 | 0.77120467 |
| 73 | TESK2 | 0.76818383 |
| 74 | MAP3K10 | 0.76724988 |
| 75 | STK39 | 0.76052729 |
| 76 | ERBB4 | 0.75421806 |
| 77 | MAP4K2 | 0.73773851 |
| 78 | CDC42BPA | 0.73257674 |
| 79 | TAOK1 | 0.69336748 |
| 80 | MAP3K1 | 0.68794477 |
| 81 | SCYL2 | 0.65437019 |
| 82 | SYK | 0.64981723 |
| 83 | WNK4 | 0.63243231 |
| 84 | LRRK2 | 0.62805212 |
| 85 | STK38 | 0.62103835 |
| 86 | MUSK | 0.61541359 |
| 87 | IKBKE | 0.61103748 |
| 88 | TXK | 0.61074432 |
| 89 | PRPF4B | 0.60532845 |
| 90 | RIPK1 | 0.58963937 |
| 91 | MAP3K11 | 0.58151551 |
| 92 | EIF2AK3 | 0.57638836 |
| 93 | MET | 0.56565305 |
| 94 | PDGFRA | 0.55819835 |
| 95 | PHKG1 | 0.55605823 |
| 96 | PHKG2 | 0.55605823 |
| 97 | MST1R | 0.55577222 |
| 98 | MARK3 | 0.55177360 |
| 99 | EPHA2 | 0.54981351 |
| 100 | PRKACG | 0.52934022 |
| 101 | MAP2K2 | 0.52507636 |
| 102 | MAPK4 | 0.52503003 |
| 103 | MAP3K7 | 0.51832344 |
| 104 | LYN | 0.51542905 |
| 105 | PRKAA1 | 0.51472117 |
| 106 | MAP3K2 | 0.50749216 |
| 107 | RET | 0.50200467 |
| 108 | LCK | 0.50095011 |
| 109 | NEK9 | 0.49892539 |
| 110 | TESK1 | 0.48454010 |
| 111 | GSK3A | 0.48443012 |
| 112 | GRK6 | 0.45796586 |
| 113 | SMG1 | 0.45520110 |
| 114 | CDK3 | 0.43781038 |
| 115 | DYRK3 | 0.43641158 |
| 116 | BRSK2 | 0.41980884 |
| 117 | NTRK1 | 0.41511243 |
| 118 | FER | 0.41142957 |
| 119 | IRAK4 | 0.40187640 |
| 120 | ADRBK1 | 0.39320637 |
| 121 | PRKCI | 0.38789800 |
| 122 | PRKCH | 0.38679331 |
| 123 | RPS6KA4 | 0.37616647 |
| 124 | PRKG2 | 0.37496173 |
| 125 | TIE1 | 0.37306185 |
| 126 | IKBKB | 0.36552077 |
| 127 | MAPKAPK2 | 0.36238656 |
| 128 | RPS6KA6 | 0.35900074 |
| 129 | SIK3 | 0.34990068 |
| 130 | MTOR | 0.34495764 |
| 131 | CHUK | 0.34211868 |
| 132 | MAPK12 | 0.33842175 |
| 133 | IRAK2 | 0.33221489 |
| 134 | STK16 | 0.31922690 |
| 135 | ABL2 | 0.31290985 |
| 136 | CDK6 | 0.30322971 |
| 137 | ADRBK2 | 0.28057515 |
| 138 | PINK1 | 0.25721259 |
| 139 | MAP3K14 | 0.25656804 |
| 140 | PRKCZ | 0.23443520 |
| 141 | MAPK3 | 0.22124767 |
| 142 | CAMKK1 | 0.22031793 |
| 143 | MAP2K1 | 0.20857035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16547753 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.42970515 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23933672 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95120556 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75287325 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.65456419 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65365736 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52017991 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50082620 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43424891 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34884503 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27619288 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.16010096 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12670170 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11228064 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.11019688 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08650260 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00663887 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00139580 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99887171 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.99671087 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97392650 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95531119 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86966970 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85856488 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80828854 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78218114 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71587649 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.70702128 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65000490 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62321341 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60416119 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59053684 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53323140 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52234192 |
| 36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49786149 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49100705 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48912505 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47900914 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.47889802 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46288989 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39720979 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36891080 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35749257 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33168544 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32586190 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31076637 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27712280 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25568978 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20297943 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19435203 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.17931776 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.17207528 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.14735511 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10352542 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09146681 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08903170 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07715888 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04198275 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02985605 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98839836 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97819128 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96498971 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92393657 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92186365 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90596228 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.89730760 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88446556 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86975061 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86817801 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83931582 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80688677 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78131792 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76506972 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72845897 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72161033 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72102213 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.69665118 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69252966 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68853873 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68609705 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67763977 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.66156767 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.64608865 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64147594 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64112900 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63793509 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62796632 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61616726 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.60337332 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58420460 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57982515 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.56804238 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56764615 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53398275 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53389123 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53240967 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52502860 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51916625 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51702269 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51414437 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.51352641 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50653773 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50400820 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48913340 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48490839 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.47076706 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46470776 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46345518 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46265614 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45946221 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44546841 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43151578 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.38979139 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36198155 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36003217 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34486953 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30906990 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30191841 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27190813 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25955099 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25892535 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25742695 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20673488 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19843537 |
| 126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15693445 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14248198 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11138423 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10486117 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.10417792 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08885055 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03469112 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.02715491 |
| 134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.01144939 |
| 135 | Legionellosis_Homo sapiens_hsa05134 | 0.00823800 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0447424 |
| 137 | Pertussis_Homo sapiens_hsa05133 | -0.0163267 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0049801 |

